Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06084312 · ClinicalTrials.gov registry record
Contact Registry for Clinical Trials
A clinical trial of This is the Contact Registry, sponsored by University of Central Florida.
- Recruiting
- Registry status
- 50,000
- Enrollment target
- 1
- Study location
NCT06084312: Recruiting study of This is the Contact Registry, sponsored by University of Central Florida.
NCT06084312 is a study of This is the Contact Registry that is actively recruiting participants, run by University of Central Florida. The registered enrollment target is 50,000 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06084312, a study of This is the Contact Registry, is actively recruiting participants, sponsored by University of Central Florida.
- RECRUITING
- Registry status
- 50,000 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the Contact Registry for Clinical Trials is to develop a database/listserv of persons interested in clinical trials occurring at the University of Central Florida College of Medicine. Sign up for the UCF College of Medicine's Contact Registry for Clinical Trials to learn about clinical research and clinical trials in areas of interest to you! https://ucf.qualtrics.com/jfe/form/SV\_do4WGvKlz4f8Wwe
Conditions Studied
Study Locations (1)
Florida
- University of Central Florida - Orlando
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50,000 participants |
| Start Date | 2022-04-18 |
| Est. Completion | 2030-01 |
What NCT06084312 shows while recruiting
NCT06084312 is an observational study that tracks outcomes without assigning an intervention. Its 50,000 participants enrollment target places it among the larger protocols in the corpus.
The record links to 1 condition, with This is the Contact Registry appearing as the primary indexed condition, and to 0 interventions.
NCT06084312 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT06084312 about?
NCT06084312 is a clinical study titled "Contact Registry for Clinical Trials". The purpose of the Contact Registry for Clinical Trials is to develop a database/listserv of persons interested in clinical trials occurring at the University of Central Florida College of Medicine. Sign up for the UCF College of Medicine's Contact Registry for Clinical Trials to learn about clinic...
What is the current status of trial NCT06084312?
This trial is currently recruiting. The enrollment target is 50,000 participants. The study started on 2022-04-18. Estimated completion is 2030-01.
What conditions does trial NCT06084312 study?
This clinical trial studies the following conditions: This is the Contact Registry.
Who is sponsoring clinical trial NCT06084312?
This trial is sponsored by University of Central Florida, which has 91 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06084312 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00500123 · 50,000 participants
The Alpha-1 Foundation's and University of Florida's Alpha-1 Coded Testing (ACT) Study
- NCT01885299 · 50,000 participants
RSSearch Patient Registry-Long Term Study of Use of SRS/SBRT
- NCT03452774 · 50,000 participants
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- NCT04629586 · 50,000 participants
The T1D Exchange Registry
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI